Health
Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses – News-Medical.Net
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
The COVID-19 pandemic has taken a massive toll on human life, with the virus spreading to 188 countries and territories and infecting nearly 17 million individuals. A very significant source of uncertainty in dealing with the pandemic has been the lack of any effective antiviral or vaccine against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) despite strenuous scientific efforts.
Now, a new study published in the preprint server bioRxiv* in July 2020 reports o…
-
Noosa News23 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News22 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business8 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General17 hours ago‘Potential’ hacker contacts Qantas over data breach